Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether it is safe and effective to collect
peripheral blood hematopoietic stem cells 16 hours rather than the usual 11 hours after
administration of plerixafor.